北方药学
北方藥學
북방약학
Journal of North Pharmacy
2015年
11期
22-23
,共2页
强化胰岛素治疗%不同血糖水平%内科脓毒症%MODS%低血糖
彊化胰島素治療%不同血糖水平%內科膿毒癥%MODS%低血糖
강화이도소치료%불동혈당수평%내과농독증%MODS%저혈당
Intensive insulin therapy%Blood glucose level%Sepsis%MODS%Hypoglycemia
目的:探讨应用强化胰岛素模式治疗不同血糖控制水平对内科脓毒症患者的影响。方法:按随机原则,符合条件的病例分成强化胰岛素治疗A组和强化胰岛素治疗B组,A组32例,B组33例。 A组血糖控制在4.4~6.1mmol/L,B组血糖控制在6.1~8.3mmol/L。对两组患者的ICU住院天数、ICU住院医疗费用、总住院天数、病死率、MODS发生率、低血糖发生率,治疗前及治疗后第五天血清CRP水平变化进行比较。结果:两组患者入重症医学科时在平均年龄、性别比例和APACH II评分上相似(P>0.05),具有可比性。两组在ICU住院时间、ICU住院费用和总住院时间差异均无统计学意义(P>0.05)。A组MODS发病率、低血糖发生率和病死率明显低于B组,差别有统计学意义(P<0.05)。两组患者治疗后的CRP水平比治疗前均有显著下降,差异有统计学意义(P<0.05)。两组患者之间比较,治疗前CRP水平无明显差异(P>0.05),治疗后A组患者CRP水平比B组患者低,有显著差异(P<0.05)。结论:对于脓毒症进行强化胰岛素治疗可以减轻炎症反应,且将血糖严格控制在4.4~6.1mmol/L水平比将血糖控制在较高水平6.1~8.3mmol/L,MODS的发病率明显降低,但同时要注意严密监测血糖,以避免低血糖给患者带来危害。
目的:探討應用彊化胰島素模式治療不同血糖控製水平對內科膿毒癥患者的影響。方法:按隨機原則,符閤條件的病例分成彊化胰島素治療A組和彊化胰島素治療B組,A組32例,B組33例。 A組血糖控製在4.4~6.1mmol/L,B組血糖控製在6.1~8.3mmol/L。對兩組患者的ICU住院天數、ICU住院醫療費用、總住院天數、病死率、MODS髮生率、低血糖髮生率,治療前及治療後第五天血清CRP水平變化進行比較。結果:兩組患者入重癥醫學科時在平均年齡、性彆比例和APACH II評分上相似(P>0.05),具有可比性。兩組在ICU住院時間、ICU住院費用和總住院時間差異均無統計學意義(P>0.05)。A組MODS髮病率、低血糖髮生率和病死率明顯低于B組,差彆有統計學意義(P<0.05)。兩組患者治療後的CRP水平比治療前均有顯著下降,差異有統計學意義(P<0.05)。兩組患者之間比較,治療前CRP水平無明顯差異(P>0.05),治療後A組患者CRP水平比B組患者低,有顯著差異(P<0.05)。結論:對于膿毒癥進行彊化胰島素治療可以減輕炎癥反應,且將血糖嚴格控製在4.4~6.1mmol/L水平比將血糖控製在較高水平6.1~8.3mmol/L,MODS的髮病率明顯降低,但同時要註意嚴密鑑測血糖,以避免低血糖給患者帶來危害。
목적:탐토응용강화이도소모식치료불동혈당공제수평대내과농독증환자적영향。방법:안수궤원칙,부합조건적병례분성강화이도소치료A조화강화이도소치료B조,A조32례,B조33례。 A조혈당공제재4.4~6.1mmol/L,B조혈당공제재6.1~8.3mmol/L。대량조환자적ICU주원천수、ICU주원의료비용、총주원천수、병사솔、MODS발생솔、저혈당발생솔,치료전급치료후제오천혈청CRP수평변화진행비교。결과:량조환자입중증의학과시재평균년령、성별비례화APACH II평분상상사(P>0.05),구유가비성。량조재ICU주원시간、ICU주원비용화총주원시간차이균무통계학의의(P>0.05)。A조MODS발병솔、저혈당발생솔화병사솔명현저우B조,차별유통계학의의(P<0.05)。량조환자치료후적CRP수평비치료전균유현저하강,차이유통계학의의(P<0.05)。량조환자지간비교,치료전CRP수평무명현차이(P>0.05),치료후A조환자CRP수평비B조환자저,유현저차이(P<0.05)。결론:대우농독증진행강화이도소치료가이감경염증반응,차장혈당엄격공제재4.4~6.1mmol/L수평비장혈당공제재교고수평6.1~8.3mmol/L,MODS적발병솔명현강저,단동시요주의엄밀감측혈당,이피면저혈당급환자대래위해。
Objective :To investigate the effects of intensive insulin therapy in different levels of blood glucose control in patients with sepsis of medicine. Methods: The patients who meet the conditions of intensive insulin therapy were randomly divided into group A and B. There were 32 people in group A and 33 people in group B. The days in the ICU,ICU hospitalization expenses,The total days in hospital, mortality,the incidence of MODS and hypoglycemia,serum C—reactive protein before and after treatment were compared. Results:The average age, sex ratio and APACH II scores in two groups were similar (P>0.05).In addition, the days in the ICU , ICU hospitalization expenses and the total days in hospital were not statistically different (P>0.05).The CRP levels after treatment in both groups were significantly lower than that before treatment (P<0.05). However, after treatment, the CRP level of group A was lower than that of group B (P<0.05).Conclusions: For patients with sepsis, intensive insulin therapy can reduce inflammation, and it is more obvious in the blood glucose level of 4.4~6.1mmol/L than that of 6.1~8.3mmol/L.Strict control of blood glucose level in 4.4~6.1mmol/L, the incidence of MODS can be significantly reduced. Meanwhile, we should pay attention to monitor blood sugar in order to avoid the harm of hypoglycemia.